HN2001000038A - Sistema de administracion oral controlada para la ingestion diaria de ciprofloxacina - Google Patents

Sistema de administracion oral controlada para la ingestion diaria de ciprofloxacina

Info

Publication number
HN2001000038A
HN2001000038A HN2001000038A HN2001000038A HN2001000038A HN 2001000038 A HN2001000038 A HN 2001000038A HN 2001000038 A HN2001000038 A HN 2001000038A HN 2001000038 A HN2001000038 A HN 2001000038A HN 2001000038 A HN2001000038 A HN 2001000038A
Authority
HN
Honduras
Prior art keywords
agent
ciprofloxacine
oral administration
administration system
daily intake
Prior art date
Application number
HN2001000038A
Other languages
English (en)
Spanish (es)
Inventor
Naresh Talwar
John N Staniforth
Ashok Rampal
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of HN2001000038A publication Critical patent/HN2001000038A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HN2001000038A 2000-03-03 2001-03-02 Sistema de administracion oral controlada para la ingestion diaria de ciprofloxacina HN2001000038A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51788700A 2000-03-03 2000-03-03

Publications (1)

Publication Number Publication Date
HN2001000038A true HN2001000038A (es) 2005-03-23

Family

ID=24061635

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2001000038A HN2001000038A (es) 2000-03-03 2001-03-02 Sistema de administracion oral controlada para la ingestion diaria de ciprofloxacina

Country Status (31)

Country Link
EP (1) EP1263409A1 (et)
JP (1) JP2003525229A (et)
KR (1) KR20030009374A (et)
CN (1) CN1420763A (et)
AP (2) AP2001002084A0 (et)
AR (1) AR032614A1 (et)
AU (1) AU3589701A (et)
BG (1) BG107055A (et)
BR (1) BR0108958A (et)
CA (1) CA2400950A1 (et)
CZ (1) CZ20022883A3 (et)
DO (1) DOP2001000130A (et)
EA (1) EA200200914A1 (et)
EC (1) ECSP013952A (et)
EE (1) EE200200497A (et)
GT (1) GT200100033A (et)
HN (1) HN2001000038A (et)
HR (1) HRP20020715A2 (et)
HU (1) HUP0204417A3 (et)
IL (1) IL151553A0 (et)
IS (1) IS6532A (et)
MX (1) MXPA02008568A (et)
NO (1) NO20024108L (et)
NZ (1) NZ520927A (et)
OA (1) OA12381A (et)
PE (1) PE20011113A1 (et)
PL (1) PL365071A1 (et)
SK (1) SK12542002A3 (et)
WO (1) WO2001064183A1 (et)
YU (1) YU66202A (et)
ZA (1) ZA200206764B (et)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
US20030229101A1 (en) * 2002-06-06 2003-12-11 Sherman Bernard Charles Tablets comprising ciprofloxacin hydrochloride
DE10351448A1 (de) 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
EP1745775B1 (en) * 2005-07-19 2008-05-28 Ethypharm Gastroretentive formulations and manufacturing process thereof.
EP1880722B1 (en) * 2006-07-19 2010-03-17 Tabuk Pharmaceutical Manufacturing Co. Pharmaceutical compositions of ciprofloxacin
WO2016115253A1 (en) 2015-01-14 2016-07-21 The Regents Of The University Ofcolordo, A Body Corporate Insulin mimotopes and methods of using the same
EP3419669A4 (en) * 2016-02-23 2019-10-30 Matripharm International Inc. DOUBLE-SPEED RELEASE COMPOSITION WITH HIGH MEDICAL DRUG CHARGE
AU2017236977B2 (en) 2016-03-24 2022-05-26 Immunomolecular Therapeutics, Inc. Methods of treating autoimmune disease
US11052060B2 (en) 2018-02-12 2021-07-06 The Regents Of The University Of Colorado, A Body Corporate Compounds and methods for treating autoimmunity
US11013707B2 (en) 2018-03-23 2021-05-25 The Regents Of The University Of Colorado, A Body Corporate Administration of oral methyldopa
CN109806237A (zh) * 2019-03-13 2019-05-28 悦康药业集团上海制药有限公司 一种乳酸环丙沙星泡腾片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
JPH0624959A (ja) * 1991-10-04 1994-02-01 Bayer Yakuhin Kk 胃内浮遊型薬物徐放性固形製剤
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
DE19839057A1 (de) * 1998-08-28 2000-03-02 Koch Berthold Spülluft-Regler für eine Trockenvorrichtung für Druckluft
EA004443B1 (ru) * 1998-09-14 2004-04-29 Рэнбакси Лабораториз Лимитед Лекарственная форма для контролируемого высвобождения ципрофлоксацина для приема один раз в день

Also Published As

Publication number Publication date
OA12381A (en) 2004-09-06
CZ20022883A3 (cs) 2003-04-16
KR20030009374A (ko) 2003-01-29
WO2001064183A1 (en) 2001-09-07
IS6532A (is) 2002-08-28
EP1263409A1 (en) 2002-12-11
CN1420763A (zh) 2003-05-28
NO20024108D0 (no) 2002-08-28
AU3589701A (en) 2001-09-12
BG107055A (bg) 2003-06-30
MXPA02008568A (es) 2003-02-24
HRP20020715A2 (en) 2004-12-31
AP2002002627A0 (en) 2002-09-30
IL151553A0 (en) 2003-04-10
PL365071A1 (en) 2004-12-27
AP1485A (en) 2005-10-31
NO20024108L (no) 2002-10-25
GT200100033A (es) 2001-10-25
HUP0204417A2 (en) 2003-05-28
AR032614A1 (es) 2003-11-19
CA2400950A1 (en) 2001-09-07
PE20011113A1 (es) 2001-10-14
YU66202A (sh) 2005-09-19
EA200200914A1 (ru) 2003-02-27
ZA200206764B (en) 2003-03-04
BR0108958A (pt) 2003-09-30
HUP0204417A3 (en) 2005-03-29
NZ520927A (en) 2003-06-30
DOP2001000130A (es) 2004-03-31
SK12542002A3 (sk) 2003-05-02
JP2003525229A (ja) 2003-08-26
AP2001002084A0 (en) 2001-03-31
EE200200497A (et) 2004-02-16
ECSP013952A (es) 2002-04-23

Similar Documents

Publication Publication Date Title
AR022672A1 (es) Una composicion farmaceutica en forma de tabletas o capsulas que constituyen un metodo de administracion oral de una droga
AR049985A1 (es) Tratamiento de combinacion para enfermedades malignas no hematologicas
NO993520L (no) Doseringsformer og fremgangsmÕte for Õ bedre erektil dysfunksjon
BRPI0517891A (pt) composições compreendendo azelastina e métodos de uso das mesmas
ES2109899T1 (es) Metodo, composiciones y kits para aumentar la biodisponibilidad oral de agentes farmaceuticos.
GT199900151A (es) Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacial.
BR9916224A (pt) Forma de dosagem farmacêutica oral, processos para a manufatura de uma forma de dosagem fixa, para o tratamento e a profilaxia de distúrbios gastrintestinais e para evitar efeitos colaterias gastrintestinais, uso de uma forma de dosagem, combinação, e, embalagem tipo ampola
UY30537A1 (es) Formulaciones de flibanserina y metodo para fabricarlas
CR8352A (es) Formulaciones farmaceuticas, procedimientos y pautas de dosificacion para el tratamiento y prevencion de sindromes coronarios agudos
BR0109779A (pt) Soluções moleculares hidrofìlicas dispersas de carvedilol
EA200501203A1 (ru) Жидкие фармацевтические композиции палоносетрона
AR022589A1 (es) UNA CÁPSULA QUE COMPRENDE UNA COMPOSICIoN FARMACÉUTICA ESPONTÁNEAMENTE DISPERSABLE PARA LA ADMINISTRACIoN ORAL, UNA COMPOSICIoN FARMACÉUTICA ESPONTÁNEAMENTE DISPERSABLE PARA LA ADMINISTRACIoN ORAL Y EL USO PARA LA PREPARACIoN DE UN MEDICAMENTO PARA EL TRATAMIENTO DEL CÁNCER
HN2001000038A (es) Sistema de administracion oral controlada para la ingestion diaria de ciprofloxacina
ECSP034826A (es) Método para fabricar una composición farmacéutica de dosis baja
DE50203456D1 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
ATE292453T1 (de) Antivirale arznei
AR030039A1 (es) Composicion farmaceutica que comprende una droga inhibidora selectiva de la ciclooxigenasa-2, su uso en la fabricacion de un medicamento para tratar o prevenir afecciones mediadas por la ciclooxigenasa-2 y metodo para hacer dicho medicamento
BR0014826A (pt) Imidazo-3-il-aminas bicìclicas, procedimento de sua preparação e medicamentos que as contêm
DE60205905D1 (de) Pharmazeutische zusammensetzung zur orale verabreichung mit verbesserter bioverfügbarkeit
ES2139842T3 (es) Uso de la melatonina para tratar a pacientes que sufren drogodependencia.
BR0116060A (pt) Composição farmacêutica de dronedarona para administração parenteral
AR034142A1 (es) Una composicion farmaceutica, metodo para fabricar un medicamento en base a dicha composicion y uso de la composicion
RU2011113733A (ru) Производные 1-амино-алкилциклогексана для лечения когнитивного нарушения при шуме в ушах
ATE462419T1 (de) Orale pharmazeutische zusammensetzung für weichkapseln mit vinorelbin und behandlungsverfahren
UY26176A1 (es) Formas polimorfas de un citrato de azobiciclo (2,2,2) octan- 3-amina y sus composiciones farmacéuticas.